Table 3:

Predictors of branch occlusion following coverage

ParameterBranch Occlusion (No.) (%)P Value
Not Occluded (n = 203)Occluded (n = 25)
Sex
    Female108 (87.1%)16 (12.9%).3
    Male95 (91.3%)9 (8.7%)
Median age (range) (yr)59.5 (29–82)61 (42–78).56
Smokinga
    Yes53 (82.8%)11 (17.2%).1
    No137 (90.7%)14 (9.3%)
Presenting symptoms
    Asymptomatic32 (72.7%)12 (27.3%)<.001
    Headache/dizziness38 (88.4%)5 (11.5%)
    Neurologic deficit133 (94.3%)8 (5.7%)
Subarachnoid hemorrhage
    No141 (87.6%)20 (12.4%).36
    Acute (<24 hr)25 (96.2%)1 (3.8%)
    Immediate (<2 wk)11 (100%)0%
    Remote (>2 wk)26 (86.7%)4 (13.3%)
Pretreatment mRS
    0–2160 (87.4%)23 (12.6%).12
    3–543 (95.6%)2 (4.4%)
Aneurysm shape
    Saccular74 (84.1%)14 (15.9%).18
    Fusiform89 (91.8%)8 (8.2%)
    Dissecting38 (92.7%)3 (7.3%)
Aneurysm measurements
    Maximal diameter
        <7 mm32 (84.2%)6 (15.8%).23
        7–12 mm50 (84.7%)9 (15.3%)
        13–24 mm52 (89.7%)6 (10.3%)
        >24 mm69 (94.5%)4 (5.5%)
Daughter sac
    Yes45 (90%)5 (10%).8
    No158 (88.8%)20 (11.2%)
Intra-aneurysmal thrombus
    Yes68 (94.4%)4 (5.6%).08
    No135 (86.5%)21 (13.5%)
Prior treatment
    No174 (88.3%)23 (11.7%).8
    Endovascular25 (92.6%)2 (7.4%)
    Surgery3 (100%)0%
    Both1 (100%)0%
Platelet function testing
    Yes128 (85.3%)22 (14.7%).01
    No75 (96.2%)3 (3.8%)
Clopidogrel respondersb
    Yes110 (86.6%)17 (13.4%).3
    No18 (78.3%)5 (21.7%)
Adjunctive coiling
    Yes75 (88.2%)10 (11.8%).77
    No128 (89.5%)15 (10.5%)
No. of Pipelines deployed (median) (range)1 (1–14)1 (1–4).33
Length of procedure (median) (range) (min)110 (22–410)114 (32–271).8
Branch
    VA15 (65.2%)8 (34.8%).001
    PICA45 (91.8%)4 (8.2%)
    AICA72 (92.3%)6 (7.7%)
    SCA58 (95.1%)3 (4.9%)
    PCA13 (76.5%)4 (23.5%)
No. of covered branches in same procedure
    137 (97.4%)1 (2.6%).07
    ≥2166 (87.4%)24 (12.6%)
  • Note:—SCA indicates superior cerebellar artery.

  • a Data are missing for 13 branches.

  • b Among patients with platelet function testing.